Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma
Maximiliano Servín-Rojas(Twitter (United States)), Zhi Ven Fong(Twitter (United States)), Carlos Fernández‐del Castillo(Massachusetts General Hospital), Cristina R. Ferrone(Twitter (United States)), Hang Lee(Massachusetts General Hospital), Fidel López‐Verdugo(Twitter (United States)), Guoliang Qiao(Massachusetts General Hospital), Darío M. Rocha-Castellanos(Twitter (United States)), Keith D. Lillemoe(Massachusetts General Hospital), Motaz Qadan(Massachusetts General Hospital)
Cited by 7
Abstract
Related Papers
AJCC Cancer Staging Manual
|Unknown|2016|17.4k
Cancer Statistics, 2021
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al.|CA A Cancer Journal for Clinicians|2021|17.3k
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al.|Journal of the National Comprehensive Cancer Network|2021|1.3k